Platelet Rich Plasma in Reconstructive Periodontal Therapy by Yılmaz, Selcuk et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Platelet Rich Plasma in Reconstructive 
Periodontal Therapy 
Selcuk Yılmaz, Gokser Cakar 
and Sebnem Dirikan Ipci 
Yeditepe University, Faculty of Dentistry, Istanbul, 
Turkiye 
1. Introduction 
1.1 Regenerative periodontal therapy 
The goal of periodontal therapy is to improve periodontal health and thereby to satisfy the 
patient’s esthetic and functional needs or demands. To achieve this goal, most periodontal 
treatments aim to reduce probing depths and maintain or improve attachment levels and 
these parameters are used as surrogates of improved tooth retention. Conventional 
periodontal therapy includes non-surgical treatment as well as a variety of surgical 
approaches. In such treatments, histologic analysis revealed that periodontal healing occurs 
with repair rather than regeneration (Listgarten & Rosenberg, 1979). In repair, long 
junctional epithelium exists between the treated root surface and alveolar bone (Caton & 
Greenstein, 1993). However, over the last three decades, the major goal of periodontal 
therapy has been shifted from repair to reconstruction of periodontal tissues thereby 
reversing the damage to the periodontium caused by the disease process.  
“True periodontal regeneration” is the reformation of a functionally oriented periodontal 
ligament with collagen fibers inserting in both regrown alveolar bone and reformed 
cementum over a previously diseased root surface. The first evolutionary stage of 
periodontal regeneration focused on using a variety of bone graft materials. A number of 
techniques and autogenic, allogenic, xenogenic and alloplastic bone graft materials have 
been used for regeneration purpose (Brunswold & Mellonig, 1993). Although significant 
clinical improvements in terms of probing depth reduction, attachment and bone gains were 
obtained, the results of the histological studies reported that new attachment achieved by 
bone grafts was usually a result of the formation of long junctional epithelium with slight or 
no new connective tissue attachment and negligible new cementum formation. Since these 
techniques have had limited success, more effective regenerative approaches have been 
suggested that utilize tissue-engineering techniques. 
The concept of tissue engineering in periodontics began with guided tissue regeneration 
(GTR), a mechanical approach utilizing nonresorbable or bioabsorbable membranes to 
regenerate periodontal defects. GTR is a technique in which the placement of an occlusive 
membrane guides progenitor cells, residing in the periodontal ligament to repopulate the 
osseous defects in order to form new tooth supporting tissues (Nyman et al., 1982). The 
evidence, in fact, demonstrated that treatment of two- and three- wall intrabony defects with 
GTR has yielded successful clinical results in numerous studies and could promote 
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periodontal regeneration in terms of true new attachment with nonresorbable as well as 
bioabsorbable barrier membranes (Cortellini & Tonetti, 2000). Since the improvement of the 
fibrous attachment level seems to be easier to obtain than a corresponding improvement in 
bone level with the utilization of GTR technique, it is utmost important that the space 
underneath the barrier must be preserved for an adequate period of time during healing for 
complete periodontal regeneration to occur. On the other hand, in cases where the 
membrane collapsed into the defects, reduced amounts of bone were formed due to the lack 
of space for progenitor cell population. In the light of the above, bone grafting technique has 
been an option in creating a space for the regenerating tissues underneath the membranes 
and also suggests the use of additional osteoconductive and/or partially osteoinductive 
properties of the graft materials. Combined usage of bone graft materials with GTR 
technique generally resulted in similar or more bone gain with the reported GTR studies 
alone (Paolantonio, 2002; Nygaard-Ostby et al., 2008). Although GTR and combined 
techniques successfully promote regrowth of the destroyed periodontium, application of the 
method is often difficult while there is substantial variation in clinical predictability, degree 
of efficacy, and histologic outcomes.  
Shortcomings associated with GTR and advances in molecular/developmental biology set 
the ground for a new concept in periodontal regeneration by emphasizing the importance of 
biologic mediators.  
Enamel matrix protein is one of the biologic mediators used for regeneration purpose. The 
discovery of the presence of the enamel matrix layer between the peripheral dentin and the 
developing cementum, periodontal ligament and alveolar bone formation, has provided the 
fundamental concept for enamel matrix protein derivative (EMD)-supported tissue 
engineering in regenerative periodontal therapy. General conclusions about the clinical 
relevance of EMD are limited by the high level of heterogeneity across the studies. Some 
studies have reported superior effects of EMD, other studies failed to present any additional 
effects (Trombelli, 2005). Histological data indicate that the application of EMD on the 
diseased root surfaces enhances the formation of a new connective tissue attachment (i.e. 
new cementum with inserting collagen fibers) and of new alveolar bone (Bosshardt, 2008). 
However, it has been suggested that there exists a possible limitation to the regenerative 
capability of EMD, related to its semi-fluid consistency and lack of space making effect 
(Mellonig, 1999). Therefore, combining EMD with a graft material, will overcome the 
problem of flap collapse and space maintenance when using it alone. Thus, more recently 
prominence has been given to the use of EMD in combination with graft materials (Scheyer 
et al., 2002; Bosshardt, 2008). While bone grafts intended to promote bone formation, their 
combination with EMD would designate a biological effect on the cascade of events leading 
to periodontal regeneration. Some studies indicate that the clinical outcomes of EMD may 
be improved when used in combination with bone grafts with respect to EMD alone (Kuru 
et al., 2006; Yılmaz et al., 2010b). In contrast, limited evidence seems to demonstrate no 
additional effect of EMD over the regenerative potential of the bone grafts (Scheyer et al., 
2002).  
2. Polypeptide growth factors 
Recently, there has been a tremendous interest in polypeptide growth factors (PGFs) as 
another biologic mediator in periodontal regeneration (Giannobile, 1996). They are an 
enchanting group of agents in regeneration because of their regulatory effects on 
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proliferation and differentiation of cells from bone and connective tissues. PGFs have the 
ability to regulate biological events including cell adhesion, migration, proliferation and 
differentiation. Among all PGFs, platelet derived growth factor (PDGF) and transforming 
growth factor-β (TGF-β) have been studied most extensively. PDGF and TGF-β have been 
shown to promote cell growth and differentiation in vitro and periodontal regeneration in 
animals (Lynch et al., 1991; Rutherford et al., 1992, Sporn & Roberts, 1992). However, human 
studies concerning the effects of PGFs on periodontal regeneration in vivo are limited. In 
these studies, PDGF has been shown to exert a substantial effect on periodontal regeneration 
as measured by attachment gain and bone fill in human intrabony and furcation defects 
(Howell et al., 1997; Camelo et al., 2003). Although promising results have been obtained, 
the routine use of PDGF and TGF-β as therapeutic agents for periodontal regeneration is not 
reality yet. Recently, a convenient approach to obtain not only these PGFs but also epithelial 
growth factor, vascular endothelial growth factor, insulin-like growth factor-1, basic 
fibroblast growth factor, hepatocyte growth factor is the use of autologous platelets.  
3. What is platelet rich plasma? 
Platelet rich plasma (PRP) is a preparation, serving as an autologous source of highly 
concentrated doses of platelets. The term PRP includes a high concentration of platelets 
obtained by a single or double step centrifugation of autologous blood (Tamimi et al., 2007). 
PRP preparations have also been designated as ‘platelet pellet’, ‘autologous platelet 
concentrate’ or ‘platelet gel’ (Marx, 2001).  
Although it is not well clarified, PRP presents its effects through enhancement of soft and 
hard tissue healing processes. Since the actual amount of regenerated tissue and the course 
of soft tissue healing are dependent on the individual healing potential, which is 
significantly influenced by the presence and amount of the PGFs naturally available in the 
wound, the increased local concentrations of PGFs with the application of PRP in 
periodontal wound site enhance the healing outcome (Christgau et al., 2006a). In the early 
stages of the healing process, PGFs within PRP attract undifferentiated mesenchymal cells 
within the fibrin matrix and trigger cell division. Proliferation of connective tissue 
progenitors, stimulation of fibroblasts and osteoblast activity and angiogenesis are crucial 
steps in healing process and regeneration and it is assumed that local delivery of PRP seems 
to be responsible for all these cascade of events (Marx et al., 1998; Cheung & Griffin, 2004).  
3.1 Preparation of platelet rich plasma 
PRP can be easily prepared from patient’s own blood by centrifugation and separated into 
three fractions: platelet-poor plasma (PPP) (fibrin glue or adhesive); PRP; and red blood 
cells. Platelets are enriched by 338% in the PRP preparation. PPP is the upper layer obtained 
after blood centrifugation in which platelet counts are negligible and is composed of 
acellular plasma containing fibrinogen and plasmatic growth factors. PRP is the bottom 
layer and is a volume of autologous plasma that has a platelet concentration approximately 
3-4 times higher than baseline levels (150000-450000/μl).  
Different procedures have been established for the preparation of PRP including Curasan 
PRP kit (Curasan, Kleinostheim, Germany), platelet concentration collection system 
(3i/Implant Innovations, Palm Beach Gardens, FL) and Smart PreP (Harvest Technologies 
Corp., Plymouth, MA, USA). A variety of factors influence the reliability of these systems 
including cell separator used, centrifugation steps, amount of blood collected 
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preoperatively, baseline platelet concentration, amount of platelet concentrate obtained, 
final platelet concentration, type of blood anticoagulant and platelet activator used (Del 
Fabbro et al., 2010). Any of these factors may play a major role in PRP activation and affect 
the expected outcome in terms of biologic properties. Smart PreP is an FDA approved 
system in which PRP, PPP and autologous thrombin can be obtained. The unique property 
of the system is its autologous thrombin that is not present in any of the other systems 
which is an important step in the activation of release of PGFs from platelets. Since the 
activator of the system is autologous, there is no risk of disease transmission.  
When PRP is taken into account for use in clinical practice, clinicians may encounter with 
several issues, including the clinician’s proficiency in drawing the necessary blood, the cost 
of the procedure, the efficacy of centrifugation machine in obtaining appropriate 
concentrations of platelets, extra time and steps to prepare the coagulated PRP for its actual 
use. The centrifugation process is considered to be critical since different platelet counts 
correspond to the differences in centrifugation machines and techniques (Hanna et al., 2004; 
Weibrich et al., 2002, 2003). The PRP processed by means of Smart PreP system, ensures 
high percentages of platelet concentration with less blood drawn from the patient and with 
less complex procedures. In this system, for the PRP preparation, one hour before surgery, 
20 ml of blood was drawn from the patient through a venipuncture in the antecubital vein. 
The drawn blood was mixed with 2ml of anticoagulant solution and was then processed 
through a centrifuge to obtain 3ml of the PRP according to the manufacturer’s instructions. 
Immediately before application, this PRP was mixed with autologous thrombin. For the 
preparation of autologous thrombin, 10 ml of blood was also drawn from the antecubital 
vein. The drawn blood was mixed with 1ml of anticoagulant solution and following 45 
minutes of incubation period, was centrifuged to obtain 1ml of autologous thrombin. A 
delivery syringe was used to mix the PRP with autologous thrombin (Yılmaz et al., 2007, 
2009, 2010a, 2011).  
3.2 The use of platelet rich plasma in the treatment of periodontal intrabony defects 
During the last decade, there has been an increasing interest on the use of PRP in intraoral 
therapy including periodontal defects. The effectiveness of PRP in combination with 
different types of grafting materials, with or without EMD/GTR membranes, has been 
evaluated in regenerative periodontal therapy. Review of the literature reveals that, mostly, 
PRP is combined with bone grafts in the treatment of intrabony defects. Since the space 
maintenance of the defect is a crucial factor in periodontal regeneration, PRP’s gel-like 
consistency may complicate the healing leading to flap collapse. Yılmaz et al. (unpublished 
data), evaluated the clinical and radiographic results of PRP alone in the treatment of 
intrabony defects. The authors concluded that successful results were obtained only in 
narrow and deep defects (Figures 1a-f).  
Studies comparing the treatment of intrabony defects with PRP combined with different 
types of bone grafts with or without GTR to open flap debridement, GTR or grafts alone 
demonstrated significantly greater clinical attachment gain and defect fill following the 
combination approach (De Obarrio et al., 2000; Camargo et al., 2002; Lekovic et al., 2002; 
Hanna et al., 2004; Okuda et al., 2005; Quyang & Qiao, 2006). On the other hand, very recent 
controlled clinical studies demonstrated similar results when PRP, bone grafts and 
EMD/GTR were compared to bone grafts and GTR (Camargo et al., 2009; Christgau et al., 
2006b; Papli&Chen, 2007; Yassıbağ-Berkman et al., 2007; Piemontese et al., 2008; Döri et al., 
2007a, 2007b, 2008a, 2008b, 2009; Harnack et al., 2009). Although it is difficult to draw 
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Fig. 1. (a) Initial clinical view of the intrabony 
defect and probing depth 
Fig. 1. (b) Initial radiographic view of the 
intrabony defect 
 
Fig. 1. (c) Intrasurgical measurement of the 
intrabony defect 
Fig. 1. (d) Application of PRP alone 
 
Fig. 1. (e) 12-months clinical view of the 
intrabony defect and probing depth 
Fig. 1. (f) 12-months radiographic view of 
the intrabony defect 
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general conclusions and conflicting results exist, the pre-clinical and clinical data of PRP 
seems to be promising. 
The clinical researches on PRP and their contradictional statements warrant further 
investigations to contribute to the PRP-supported regenerative therapy. In this process, 
trials evaluating the efficacy of PRP in combination with different regenerative materials can 
still add valuable information for the clinician in decision making regarding effective and 
predictable treatment alternatives for periodontal regeneration. Therefore a series of studies 
have been performed on the effect of PRP in the treatment of periodontal intrabony defects 
by Yılmaz et al. (2007, 2009, 2010a, 2011).  
In these studies, outcome variables were soft and hard tissue measurements. For all patients, 
the following clinical parameters were recorded preoperatively and at 12 months 
postoperatively by the same calibrated examiner. A calibration exercise was carried out to 
obtain acceptable intra-examiner reproducibility (Sculean et al., 2005). Intraexaminer 
calibration was performed as follows: five patients, not included in the study, with at least 
four teeth of probing depth ≥5 mm on at least one aspect of each tooth, were evaluated by 
the examiner on two seperate sessions with 48 h interval. The examiner was accepted as 
calibrated if measurements at baseline and at 48 h were similar to the millimeter at ≥90%. 
Plaque index was measured according to Silness & Löe (1964) and sulcus bleeding index 
according to Mühlemann & Son (1971). Probing depth, relative attachment level, marginal 
recession and probing bone level were measured to the nearest millimeter with a calibrated 
periodontal probe (PCP 15 UNC, Hu-Friedy, Chicago, IL, USA) using an individual occlusal 
stent as a reference point for probe placement. Occlusal stents for positioning measuring 
probes were fabricated with cold-cured acrylic resin on a cast model obtained from an 
alginate impression. It was produced so that it covered the occlusal surfaces of the tooth 
being treated and the occlusal surfaces of at least one tooth in the mesial and distal 
directions. It was also extended apically on the buccal and lingual surfaces to cover the 
coronal third of the teeth. Six grooves were placed so that the post-surgical measurements 
could be at the same position and angulation as those made prior to surgery. Probing depth 
was the distance between the free gingival margin and the probeable bottom of the pocket, 
relative attachment level was the distance between the probeable bottom of the pocket and 
the edge of the stent, recession was the distance between the free gingival margin and the 
edge of the stent and probing bone level was the distance between the probeable bone crest 
and the edge of the stent (Figure 2).  
Probing bone level was measured under local anesthesia by transgingival probing 
(sounding). The probe was forced through the soft tissue toward the bone until definite 
resistance was met (Kersten et al., 1992). Plaque index was evaluated at 4 periodontal sites 
(mesio-buccal, mid-buccal, disto-buccal, mid-lingual) whereas other measurements were 
made at 6 points (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, and 
disto-lingual). Measurements where the edge of the stents was taken as the reference point 
were relative values (relative attachment level, recession, probing bone level) to evaluate the 
attachment loss/gain, marginal soft tissue level change, and clinical bone loss/gain.  
Pre-operative and 12-month post-operative intra-oral radiographs were taken by the 
paralleling technique using a film holder device (RWT® Standard Film Holder System; bite 
blocks, indicator arms, aiming rings; Kentzler-Kaschner Dental GmbH, Ellwagen/Jagst, 
Germany) for the evaluation of radiographic bone level connected to an acrylic dental splint 
(individual) to achieve identical film placement at each evaluation with the aim of 
standardization. The film holder was coupled to the X-ray tube via an adapter (RWT® 
 
www.intechopen.com




RAL: Relative Attachment Level
REC: Recession






Fig. 2. Clinical measurements 
Standard Film Holder System; aiming rings; Kentzler-Kaschner Dental GmbH, 
Ellwagen/Jagst, Germany). Pre- and post-operative radiograph pairs were independently 
assessed on a light box by 3 experienced clinicians who were not told which radiograph was 
which. The mode (most frequent) count was accepted. When measuring radiographic bone 
level, the 3 investigators were blinded with respect to the clinical measurements and had to 
reach agreement in terms of the location of both anatomical and bone loss landmarks. 
Radiographic measurements were obtained utilizing an adhesive millimeter grid (X-ray 
Grid, 3-4 cm, Meyer Haake GmbH, Oberursel, Germany). The differences between pre- and 
post-operative radiographic bone level measurements were considered as the radiographic 
bone loss/gain.  
Besides these clinical and radiographic measurements, during operations, distance from the 
edge of the occlusal stent to the bottom of the defect (A) and distance from the edge of the 
stent to the most coronal extension of the alveolar bone crest (B) were measured. The 
intrabony component of the defects was defined as A-B (Figure 3).  
The pioneering study was a case report evaluating the clinical, radiographic and re-entry 
results of a generalized aggressive periodontitis patient with wide intrabony periodontal 
defects treated with combined PRP and bovine derived xenograft (BDX) (Yılmaz et al., 
2007). At 12 months postoperatively, clinical and radiographic measurements together with 
re-entry results showed marked improvements from baseline with increased stabilization of 
whole dentition including the hopeless teeth. In the light of this report, the authors 
emphasized that the surgical technique together with the materials used may be a possible 
solution for extensive bone loss in patients with generalized aggressive periodontitis 
(Figures 4a-g). 
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Fig. 4. (a) Initial clinical view of the intrabony 
defect and probing depth 
Fig. 4. (b) Initial radiographic view of the 
intrabony defect 
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Fig. 4. (c) Intrasurgical measurement of the 
intrabony defect 
Fig. 4. (d) Application of PRP and BDX 
combination 
 
Fig. 4. (e) Application of PRP Fig. 4. (f) 12-months radiographic view of 
the intrabony defect  
 
Fig. 4. (g) Re-entry at 12-months 
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The consecutive study investigated the effectiveness of PRP and BDX combination in the 
treatment of deep intrabony defects with an emphasis on the evaluation of early wound 
healing (Yılmaz et al., 2009). A total of 85 intrabony defects with an intrabony component of 
≥3mm were selected in 20 advanced chronic periodontitis patients. Defects were surgically 
treated with PRP/BDX. At baseline and 12 months after surgery, the following parameters 
were recorded: plaque and sulcus bleeding indices, probing depth, relative attachment level, 
marginal recession, probing bone and radiographic bone levels. Postoperative healing was 
evaluated by an early healing index at 1 and 2 weeks after surgery. At 12 months, all clinical 
and radiographic parameters were improved ( p<0.001). The mean changes at 12 months 
were: probing depth reduction of 4.78±1.20 mm, attachment gain of 4.24±1.03 mm, recession 
of 0.54±0.34 mm, clinical bone gain of 3.75±0.97 mm, and radiographic bone gain of 
3.79±1.02 mm, respectively. Two weeks after surgery, primary closure was maintained in 
95% of the defect sites. Treatment with a combination of PRP and BDX leads to a 
significantly favorable clinical and radiographic improvement in deep intrabony 
periodontal defects (Figures 5a-h). 
 
 
Fig. 5. (a) Initial clinical view of the intrabony 
defect and probing depth 
Fig. 5. (b) Initial radiographic view of the 
intrabony defect 
 
Fig. 5. (c) Intrasurgical measurement of the 
intrabony defect 
Fig. 5. (d) Application of PRP and BDX 
combination 
 
Fig. 5. (e) Application of PRP Fig. 5. (f) 12-months clinical view of the 
intrabony defect  
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Fig. 5. (g) 12-months radiographic view of the 
intrabony defect 
Fig. 5. (h) Re-entry at 12-months  
The most common environmental risk factor jeopardizing the outcomes of periodontal 
regenerative therapy is smoking. Smokers showed a significantly less favourable response 
compared with non-smokers after regenerative procedures (Tonetti et al., 1995; Trombelli & 
Scabbia, 1997; Trombelli et al., 1997; Zucchelli et al., 2002; Stavropoulos et al., 2004). The 
precise mechanisms by which smoking interferes with periodontal regenerative healing are 
not completely understood. It can be hypothesized that any substance that might jeopardize 
the function of cells capable of periodontal regeneration could also impair tissue repair and 
regeneration (Balaji, 2008). Smoking byproducts such as nicotine and cotinine may inhibit 
the attachment, proliferation and chemotaxis of human periodontal ligament fibroblasts 
(Giannopoulou et al., 1999; James et al., 1999). In the literature, there is a body of clinical 
evidence supporting the negative influence of smoking on the outcome of regenerative 
procedures, mostly GTR (Tonetti et al., 1995; Trombelli & Scabbia, 1997; Trombelli et al., 
1997; Zucchelli et al., 2002; Stavropoulos et al., 2004). However, there are no data on the 
effect of smoking status on the clinical and radiographic outcomes of a procedure based on 
the usage of PRP in intrabony defects. In order to clarify this issue, the healing response of 
intrabony defects following regenerative treatment with PRP/BDX was evaluated in 
smokers and non-smokers (Yılmaz et al., 2010a). A total of 24 advanced chronic 
periodontitis patients, 12 smokers and 12 non-smokers, with 113 intrabony defects with an 
intrabony component of ≥3mm were included in this study. Defects were surgically treated 
with PRP/BDX. At baseline and 12 months after surgery, plaque and sulcus bleeding 
indices, probing depth, relative attachment level, marginal recession, probing and 
radiographic bone levels were recorded. Considering the soft tissue measurements, smokers 
and non-smokers presented a mean probing depth reduction of 3.97±0.76 mm and 4.63±0.52 
mm, recession of 0.76±0.44 mm and 0.50±0.12 mm and attachment gain of 3.26±0.42 mm and 
4.06±0.40 mm, respectively. Evaluation of the hard tissue findings revealed that the mean 
clinical and radiographic bone gains in smokers and non-smokers were 2.83±0.47 mm and 
3.63±0.38 mm, 2.98±0.38 mm and 3.67±0.48 mm, respectively. Inter-group differences for 
probing depth reduction (p<0.05), attachment (p<0.001), clinical (p<0.001) and radiographic 
bone gains (p<0.001) were found to be significant between smokers and non-smokers. These 
results emphasized that treatment outcome following PRP/BDX application in intrabony 
defects is impaired with smoking. 
All patients participating in these studies tolerated the surgical procedures well. No 
complications such as infection, abscess formation and tissue necrosis were observed at any 
treated site. Additionally, an early healing index representing the early wound healing was 
evaluated (Wachtel et al., 2003). This index not only differentiates different degrees of 
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exposure, but also records the amount of fibrin formation when complete closure is present. 
Clinical experience has shown that the most rapid and uneventful healing is associated with 
no or minimal fibrin formation. In all patients, at 1 and 2 weeks, almost all sites were 
completely closed. It has been reported that biological, physical and chemical properties of 
PRP may effect the wound healing (Okuda et al., 2003). During the early stages of wound 
healing, PGFs lead to a cellular and molecular events that result in wound healing in an 
orchestrated manner (Wikesjö et al., 1992). The effects of PGFs on cells and high content of 
fibrinogen (fibrin glue) that promotes a favorable scaffold for cellular migration are essential 
steps in the regeneration of periodontal defects. The PRP preparation presents a sticky 
characteristic, which works as a hemostatic and stabilizing agent and may aid the 
immobilization of the blood clot and bone graft in the defect area (Kawase et al., 2003). 
Blood clot immobilization has been suggested to be an important event in the early phases 
of wound healing in periodontal regenerative procedures (Polson & Proye, 1983). Moreover, 
establishing nontension primary wound closure of various soft tissue flaps is paramount for 
optimal postoperative wound healing (Kuru et al., 2006). Regenerative surgical procedures 
that require clinical flap manipulation also require excellence in suturing. When the proper 
suture technique is used, primary intention healing occurs. Accurate apposition of surgical 
flaps is significant to patient comfort, blood clot stabilization and prevention of unnecessary 
bone destruction. Interrupted suture techniques achieve excellent clinical results when used 
for wound closure with tension-free flaps. In these studies, interrupted sutures were used 
and flaps were placed back to their original places. The sutures were free of tension, 
obtaining a complete coverage of the intrabony defects. Collectively, the enhanced wound 
healing potential of PRP and primary wound closure may explain the improved early 
healing index results found in these studies. A shortcoming encountered with the currently 
available modalities of periodontal regenerative therapy is limited predictability. Even 
though the various modalities of osseous grafting, GTR, and, in particular, the combination 
of both, have been shown to be effective in promoting clinical and histologic periodontal 
regeneration, complete restoration of the attachment apparatus in every treated defect is still 
not a reality (Cortellini & Tonetti, 2000). Furthermore, it is very difficult and expensive to 
use such materials when full mouth bone defects are present. The ability to incorporate 
PGFs into the periodontal wound healing site with the application of PRP provides a 
promising approach to reach the established regenerative goals (Christgau et al., 2006a, 
2006b). It is also possible to treat multiple intrabony defects in the same mouth with PRP 
prepared with the blood drawn from the same patient. Bone grafts as autografts, allografts, 
xenografts and synthetic materials have been shown to improve attachment levels and 
promote defect fill in humans (Garret, 1996). However, they usually result in the 
development of a long junctional epithelium between the root surface and gingival 
connective tissue (Caton & Zander, 1976). Therefore, while materials intended to promote 
bone formation play an important role in periodontal therapy, their combination with 
agents like PRP, capable of enhancing cell-mediated phenomena in periodontal wound 
healing has the potential to optimize the outcome of periodontal regeneration.  
Smoking, as a risk factor, affects the results of regenerative periodontal therapy with 
PRP/BDX (Yılmaz et al., 2010a). Smokers presented less favourable soft and hard tissue 
healing when compared to non-smokers. This result may be attributed to the hypothesis 
that there may be a differential susceptibility of PRP to the negative effects of smoking (due 
to nicotine and its cytotoxic and vasoactive effects). In the literature, PRP was accepted as a 
practical source for PGFs required in regenerative procedures (Marx et al., 1998). Therefore, 
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any factor that might jeopardize the regenerative potential of PRP by adversely affecting 
PGF production could also influence the regenerative outcomes (Balaji, 2008). It has been 
reported that smoking down-regulates hydroxyproline and collagen production (Jorgensen 
et al., 1998). Hydroxyproline and collagen are essential for the production and maintenance 
of connective tissue. The presence of nicotine on root surfaces in smokers has also been 
documented (Cuff et al., 1989). This nicotine can be stored in fibroblasts, which alters 
fibroblast function and proliferation (Peacock et al., 1993; Tipton & Dabbous, 1995). When 
fibroblasts are exposed to nicotine, cellular changes can occur (Hanes et al., 1991). This 
altered function of fibroblasts due to nicotine exposure could also be the cause of the poor 
periodontal wound healing. These combined effects of smoking may lead to less favourable 
outcomes following regenerative periodontal procedures. 
3.3 Platelet rich plasma versus platelet poor plasma 
Few studies have attempted to evaluate the effects of PPP which is poor in platelets. An 
animal experimental study provides an evidence of the positive role of PPP as a potential 
osteoinductive biologic tissue adhesive (Abiraman et al., 2002). In a recent animal study, it 
has been shown that PPP enhances bone formation based on radiographic and histologic 
findings (Findikcioglu et al., 2009). It has also been demonstrated that PPP is capable of 
stimulating osteoblastic proliferation, increasing DNA synthesis and performing a 
mitogenic effect of osteoblasts/periodontal ligament cells (Hamdan et al., 2009; Findikcioglu 
et al., 2009). Despite the fact that pre-clinical data appear promising, only one clinical study 
is available in the literature for the use of PPP in the treatment of intrabony defects. In this 
study, the healing outcomes of intrabony defects following treatment with PRP versus PPP 
combined with BDX were assessed (Yılmaz et al., 2011). Using a split mouth design, a total 
of 79 intrabony defects with an intrabony component of ≥3 mm in 20 patients were treated 
either with PRP/BDX or PPP/BDX. At baseline and 12 months after surgery, plaque and 
sulcus bleeding indices, probing depth, relative attachment level, recession, probing and 
radiographic bone levels were recorded. After 12 months, PRP/BDX and PPP/BDX groups, 
presented a mean probing depth reduction of 3.87±0.86 mm and 3.76±0.80 mm, recession of 
1.35±0.68 mm and 1.58±0.54 mm, attachment gain of 2.51±0.97 mm and 2.18±0.87 mm, 
clinical bone gain of 2.18±0.86 mm and 2.09±0.89 mm, and radiographic bone gain of 
2.11±0.87 mm and 2.19±0.96 mm, respectively. Inter-group differences were found to be 
insignificant. These results suggest that the outcomes of the treatment following PRP/BDX 
and PPP/BDX applications in intrabony defects are similar. When the platelet counts are 
taken into consideration, plasma poor in platelets, seems to demonstrate similar clinical 
efficacy as the plasma rich in platelets (Figures 6a-h). 
PRP is an application of tissue engineering and can be considered as a storage vehicle for 
growth factors. However, previously demonstrated platelet count related actions may not 
solely reflect the mechanism of PRP and additional components of PRP and PPP also may 
have important biological activities during healing. It was suggested that PRP contains high 
concentrations of several growth factors such as PDGF and TGF-β, which may strongly 
modulate the regeneration process (Kawase et al., 2005; Christgau et al., 2006a). On the other 
hand, there may have been sufficient amounts of PGFs naturally occuring in the periodontal 
wound. Platelet activation in response to tissue damage during surgical periodontal 
procedures forms a platelet plug and blood clot to provide hemostasis and secretion of 
biologically active proteins. Thus, the therapeutical local application of PRP might have a 
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little effect on the periodontal wound healing in terms of growth factor content (Christgau et 
al., 2006a). Other than growth factors, it was also suggested that because of its fibrinogen 
content PRP reacts with thrombin to induce fibrin clot formation (Camargo et al., 2005). This 
 
 
Fig. 6. (a) Initial clinical view of the intrabony 
defect and probing depth 
Fig. 6. (b) Initial radiographic view of the 
intrabony defect 
Fig. 6. (c) Intrasurgical measurement of the 
intrabony defect 
Fig. 6. (d) Application of PPP and BDX 
combination 
 
Fig. 6. (e) Application of PPP Fig. 6. (f) 12-months clinical view of the 
intrabony defect  
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Fig. 6. (g) 12-months radiographic view of the 
intrabony defect 
     Fig. 6. (h) Re-entry at 12-months  
reaction is capable of upregulating collagen synthesis in the extracellular matrix and 
provides a scaffold for cellular migration and adhesion (Camargo et al., 2005). PPP contains 
much more fibrinogen than PRP (Gosain & Lyon, 2002). It is of interest to note that this 
fibrinogen has firmer consistency that leads to its biologic sealant activity and adhesive 
potential (Gosain & Lyon, 2002). These features may have contributed to the similar clinical 
healing results obtained in both groups. Apart from the aforementioned knowledge, 
Creeper et al. (2009) stated that both PRP and PPP are capable of inducing differentiation of 
the periodontal ligament cells and osteoblasts that are critical for periodontal and bone 
regeneration and PPP also contains certain growth factors comparable to those found in 
PRP. 
4. Conclusion 
Although complete periodontal regeneration is unpredictable with any regenerative 
therapy currently used, the use of spesific biomaterials/biologicals show strong potential 
in improving clinical results in periodontal defects. Part of the problem is that it is still 
unclear how periodontal disease effects the supporting bone's regenerative potential and 
what specific biologic factors are involved. In recent years, however, clinicians have 
begun to learn much more about how periodontal regeneration works on a cellular and 
molecular level. This is a key step to developing strategies and materials that allow 
clinicians to promote periodontal regeneration predictably. As more is learned about the 
biologic process of periodontal wound healing and regeneration, new materials and 
techniques, are expected to make the task of periodontal regeneration even more 
predictable. It is likely that some combination of techniques may eventually prove to yield 
the best results. Overall, reconstruction of lost periodontal tissues with these new 
approaches results with functionally and esthetically acceptable teeth not only for the 
dentist but also for the patient.  
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